King D J, Brunton J, Barr R D
Royal Aberdeen Children's Hospital, Scotland.
Am J Pediatr Hematol Oncol. 1988 Winter;10(4):313-5. doi: 10.1097/00043426-198824000-00008.
Three groups of patients were studied to assess the effect of oral corticosteroid therapy on erythropoiesis in vivo as measured by changes in haemoglobin concentration (Hb) and red blood cell count (RBC). Fifteen patients with acute lymphoblastic leukaemia, who were in remission and receiving pulses of vincristine and prednisone during maintenance chemotherapy, showed no rise in Hb or RBC with steroid therapy. Likewise, 15 patients completing chemotherapy for ALL did not show a rise in Hb or RBC after stopping treatment. However, 14 children with acute immune thrombocytopenic purpura demonstrated a significant increase in Hb and RBC during a course of treatment with prednisone. These findings complement the results of in vitro studies, indicating that erythropoiesis in normal human bone marrow is stimulated by corticosteroid therapy.
对三组患者进行了研究,以评估口服皮质类固醇疗法对体内红细胞生成的影响,该影响通过血红蛋白浓度(Hb)和红细胞计数(RBC)的变化来衡量。15例急性淋巴细胞白血病患者处于缓解期,在维持化疗期间接受长春新碱和泼尼松脉冲治疗,接受类固醇治疗后Hb和RBC未升高。同样,15例完成急性淋巴细胞白血病化疗的患者在停止治疗后Hb和RBC也未升高。然而,14例急性免疫性血小板减少性紫癜患儿在接受泼尼松治疗期间,Hb和RBC显著增加。这些发现补充了体外研究的结果,表明皮质类固醇疗法可刺激正常人骨髓中的红细胞生成。